Skip to content
2000
image of The Effect of Risk Factors and Clinical Complications of Chronic Kidney Disease (CKD) on Renal Arterial Resistive Index (RRI)

Abstract

Background

Chronic Kidney Disease (CKD) is a known risk factor for End-Stage Renal Disease (ESRD) and Cardiovascular Diseases (CVD). Renal Doppler Ultrasound (RDU) can detect early renal involvement in CKD using the Renal Resistive Index (RRI).

Aims

This study aimed to investigate the effects of risk factors and clinical complications associated with CKD on RRI among patients with different stages of CKD.

Methods

In this analytical cross-sectional study, 186 patients referred to Poursina Hospital for RDU were categorized into six groups (normal and five stages of CKD). We analyzed the impact of demographic factors and clinical complications on RRI across all groups.

Results

Our findings indicated that CKD prevalence was particularly high among older patients and those with CVD, type 2 diabetes mellitus (DM), and hypertension (HTN). Elevated RRI in CKD patients was significantly associated with age, CKD stage, CVD, and HTN ( < 0.05). Furthermore, RRI was higher in CKD patients with elevated serum phosphorus (P) levels, higher low-density lipoproteins (LDL), and lower calcium (Ca) and hemoglobin (Hb) levels. Based on a multivariate regression model, CVD, lower Ca, high LDL, and proteinuria were identified as independent predictors of elevated RRI ( < 0.05).

Conclusion

This study concludes that elevated RRI is associated with the severity of CKD and its clinical complications, suggesting that RRI can serve as a reliable indicator for assessing CKD patients, managing treatment, and preventing early death complications.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021346088241228184539
2025-04-10
2025-09-25

  • From This Site

    /content/journals/chyr/10.2174/0115734021346088241228184539
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Chen T.K. Knicely D.H. Grams M.E. Chronic kidney disease diagnosis and management. JAMA 2019 322 13 1294 1304 10.1001/jama.2019.14745 31573641
    [Google Scholar]
  2. Francis A. Harhay M.N. Ong A.C.M. Tummalapalli S.L. Ortiz A. Fogo A.B. Fliser D. Roy-Chaudhury P. Fontana M. Nangaku M. Wanner C. Malik C. Hradsky A. Adu D. Bavanandan S. Cusumano A. Sola L. Ulasi I. Jha V. American Society of Nephrology European Renal Association International Society of Nephrology Chronic kidney disease and the global public health agenda: An international consensus. Nat. Rev. Nephrol. 2024 20 7 473 485 10.1038/s41581‑024‑00820‑6 38570631
    [Google Scholar]
  3. Jankowski J. Floege J. Fliser D. Böhm M. Marx N. Cardiovascular disease in chronic kidney disease. Circulation 2021 143 11 1157 1172 10.1161/CIRCULATIONAHA.120.050686 33720773
    [Google Scholar]
  4. Kharsa C. Beaini C. Chelala D. Aoun M. Association of renal resistive indices with kidney disease progression and mortality. BMC Nephrol. 2023 24 1 348 10.1186/s12882‑023‑03398‑6 38017384
    [Google Scholar]
  5. Singla R.K. Kadatz M. Rohling R. Nguan C. Kidney ultrasound for nephrologists: A review. Kidney Med. 2022 4 6 100464 10.1016/j.xkme.2022.100464 35572095
    [Google Scholar]
  6. Viazzi F. Leoncini G. Derchi L.E. Pontremoli R. Ultrasound doppler renal resistive index. J. Hypertens. 2014 32 1 149 153 10.1097/HJH.0b013e328365b29c 24172238
    [Google Scholar]
  7. Darabont R. Mihalcea D. Vinereanu D. Current insights into the significance of the renal resistive index in kidney and cardiovascular disease. Diagnostics 2023 13 10 1687 10.3390/diagnostics13101687 37238172
    [Google Scholar]
  8. Boddi M. Bonizzoli M. Chiostri M. Begliomini D. Molinaro A. Tadini Buoninsegni L. Gensini G.F. Peris A. Renal resistive index and mortality in critical patients with acute kidney injury. Eur. J. Clin. Invest. 2016 46 3 242 251 10.1111/eci.12590 26728776
    [Google Scholar]
  9. Provenzano M. Rivoli L. Garofalo C. Faga T. Pelagi E. Perticone M. Serra R. Michael A. Comi N. Andreucci M. Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile. PLoS One 2020 15 4 e0230020 10.1371/journal.pone.0230020 32236125
    [Google Scholar]
  10. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002 39 2 Suppl. 1 S1 S266 [From NLM.]. 11904577
    [Google Scholar]
  11. Delanaye P. Mariat C. The applicability of eGFR equations to different populations. Nat. Rev. Nephrol. 2013 9 9 513 522 10.1038/nrneph.2013.143 23856996
    [Google Scholar]
  12. Adem M. Mekonen W. Ausman A. Ahmed M. Yimer A. Prevalence of chronic kidney disease and its associated factors among diabetes mellitus patients in Dessie Referral Hospital, South Wollo, Ethiopia. Sci. Rep. 2024 14 1 9229 10.1038/s41598‑024‑59184‑3 38649429
    [Google Scholar]
  13. Swamy S. Noor S.M. Mathew R.O. Cardiovascular disease in diabetes and chronic kidney disease. J. Clin. Med. 2023 12 22 6984 10.3390/jcm12226984 38002599
    [Google Scholar]
  14. Zoccali C. Mallamaci F. Adamczak M. Cardiovascular complications in chronic kidney disease: A review from the European renal and cardiovascular medicine working group of the European renal Association. Cardiovasc. Res. 2023 119 11 2017 2032 10.1093/cvr/cvad083
    [Google Scholar]
  15. Ikee R. Kobayashi S. Hemmi N. Imakiire T. Kikuchi Y. Moriya H. Suzuki S. Miura S. Correlation between the resistive index by doppler ultrasound and kidney function and histology. Am. J. Kidney Dis. 2005 46 4 603 609 10.1053/j.ajkd.2005.06.006 16183414
    [Google Scholar]
  16. Watanabe S. Okura T. Kurata M. Irita J. Manabe S. Miyoshi K.I. Fukuoka T. Gotoh A. Uchida K. Higaki J. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension. Clin. Exp. Hypertens. 2006 28 5 451 461 10.1080/10641960600798671 16820342
    [Google Scholar]
  17. Hanamura K. Tojo A. Kinugasa S. Asaba K. Fujita T. The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients. Int. J. Nephrol. 2012 2012 1 9 10.1155/2012/139565 23304501
    [Google Scholar]
  18. Bigé N. Lévy P.P. Callard P. Faintuch J.M. Chigot V. Jousselin V. Ronco P. Boffa J.J. Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease. BMC Nephrol. 2012 13 1 139 10.1186/1471‑2369‑13‑139 23098365
    [Google Scholar]
  19. Neupane N. Koirala K. Koirala S. Lohani B. Renal segmental artery resistive index as a non-invasive indicator of functional deterioration in patients with chronic kidney disease. Austin J Radiol 2022 9 2 1192
    [Google Scholar]
  20. Sanei Sistani S. Alidadi A. Ansari Moghadam A. Mohamadnezhad F. Heshmat Ghahderijani B. Comparison of renal arterial resistive index in type 2 diabetic nephropathy stage 0-4. Eur. J. Transl. Myol. 2019 29 4 8364 10.4081/ejtm.2019.8364 31908744
    [Google Scholar]
  21. Gigante A. Pellicano C. De Marco O. Assanto E. Sorato G. Palladini A. Rosato E. Lai S. Muscaritoli M. Cianci R. Changes in renal microcirculation in patients with nephrotic and nephritic syndrome: The role of resistive index. Microvasc. Res. 2024 152 104641 10.1016/j.mvr.2023.104641 38072161
    [Google Scholar]
  22. Kuttancheri T. Das S.K. Shetty M.S. Satish S. Bathrenathh B. Renal resistive index as a marker of histopathological damage in diabetic and non-diabetic chronic kidney disease. Egypt. J. Radiol. Nucl. Med. 2023 54 1 159 10.1186/s43055‑023‑01096‑9
    [Google Scholar]
  23. Venables H. Lennon R.I. Soleimani M. Understanding doppler renal resistive index: An exploration of clinical and theoretical determinants. Preprints 2024 10.20944/preprints202404.1200.v1
    [Google Scholar]
  24. Kim E.S. Kim H.J. Kim Y.J. Lee S.M. Lee H.J. Cho D.S. Son Y.K. Kim S.E. Kim K.H. An W.S. Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients. Kidney Res. Clin. Pract. 2013 32 4 158 163 10.1016/j.krcp.2013.09.002 26877935
    [Google Scholar]
  25. Romano G. Mioni R. Danieli N. Bertoni M. Croatto E. Merla L. Alcaro L. Pedduzza A. Metcalf X. Rigamonti A. Catena C. Sechi L.A. Colussi G. Elevated intrarenal resistive index predicted faster renal function decline and long-term mortality in non-proteinuric chronic kidney disease. J. Clin. Med. 2022 11 11 2995 10.3390/jcm11112995 35683384
    [Google Scholar]
/content/journals/chyr/10.2174/0115734021346088241228184539
Loading
The Effect of Risk Factors and Clinical Complications of Chronic Kidney Disease (CKD) on Renal Arterial Resistive Index (RRI)
Bentham Science Publishers ; https://doi.org/10.2174/0115734021346088241228184539
/content/journals/chyr/10.2174/0115734021346088241228184539
/content/journals/chyr/10.2174/0115734021346088241228184539
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: clinical complications ; stage of CKD ; risk factors ; renal resistive index ; Chronic kidney disease ; renal doppler ultrasound

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test